Cargando…
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis
BACKGROUND: Parkinson disease (PD) psychosis (PDP) is a disabling non-motor symptom. Pharmacologic treatment is limited to pimavanserin, quetiapine, and clozapine, which do not worsen parkinsonism. A Food and Drug Administration black box warning exists for antipsychotics, suggesting increased morta...
Autores principales: | Longardner, Katherine, Wright, Brenton A., Alakkas, Aljoharah, You, Hyeri, Xu, Ronghui, Liu, Lin, Nahab, Fatta B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882782/ https://www.ncbi.nlm.nih.gov/pubmed/36706079 http://dx.doi.org/10.1371/journal.pone.0278262 |
Ejemplares similares
-
Hyperglycaemia-related occipital lobe seizures
por: Alakkas, A, et al.
Publicado: (2020) -
Improving Medication Regimen Recommendation for Parkinson’s Disease Using Sensor Technology
por: Watts, Jeremy, et al.
Publicado: (2021) -
Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
por: Longardner, Katherine, et al.
Publicado: (2020) -
Treatment of Essential Tremor with Long-Chain Alcohols: Still Experimental or Ready for Prime Time?
por: Haubenberger, Dietrich, et al.
Publicado: (2014) -
Early-Onset Alzheimer's Disease Masquerading as Catatonia
por: Alakkas, Aljoharah, et al.
Publicado: (2020)